{
    "organizations": [],
    "uuid": "d166c6eb7d011fcc0fc8764dfdcb747680603718",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ardelyx-announces-pricing-of-publi/brief-ardelyx-announces-pricing-of-public-offering-of-common-stock-idUSASC0A3AZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Ardelyx Announces Pricing Of Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 22 (Reuters) - Ardelyx Inc:\n* ARDELYX ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK\n* SAYS PUBLIC OFFERING OF 12.5 MILLION COMMON SHARES PRICED AT $4.00PER SHARE\n* ARDELYX - EXPECTS TO USE NET PROCEEDS OF OFFERING TO SUPPORT ITS CLINICAL DEVELOPMENT, PRE-COMMERCIALIZATION EFFORTS FOR TENAPANOR, AMONG OTHERS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-23T06:16:00.000+03:00",
    "crawled": "2018-05-23T09:08:56.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "ardelyx",
        "inc",
        "ardelyx",
        "announces",
        "pricing",
        "public",
        "offering",
        "common",
        "stock",
        "say",
        "public",
        "offering",
        "million",
        "common",
        "share",
        "priced",
        "share",
        "ardelyx",
        "expects",
        "use",
        "net",
        "proceeds",
        "offering",
        "support",
        "clinical",
        "development",
        "effort",
        "tenapanor",
        "among",
        "others",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}